Synonyms: CM-101 | CM101
Compound class:
Antibody
Comment: Nebokitug is the INN for an anti-C-C motif chemokine ligand 24 (CCL24) monoclonal antibody (proposed INN list 131, August 2024). It is likely clinical lead CM-101 (ChemomAb Ltd.). CCL24 is a soluble cytokine that is an important regulator of inflammation and fibrosis in human diseases such as primary sclerosing cholangitis (PSC) [1], systemic sclerosis, metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). It promotes recruitment and activation of both immune cells and fibroblasts and this combined action induces over-production of extracellular matrix components that underlie fibrosis. Blocking CCL24-mediated signalling, via its receptor CCR3, with CM-101 has demonstrated therapeutic potential in preclinical PSC models [3-4].
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
13178 | nebokitug |
Synonyms ![]() |
CM-101 | CM101 |
Database Links ![]() |
|
CAS Registry No. | 2922315-59-9 (source: WHO INN record) |
GtoPdb PubChem SID | 507750300 |
Search PubMed clinical trials | nebokitug |
Search PubMed titles | nebokitug |
Search PubMed titles/abstracts | nebokitug |